Zu et al., 2023 - Google Patents
A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)–associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe …Zu et al., 2023
- Document ID
- 10923214199340566905
- Author
- Zu C
- Wu S
- Zhang M
- Wei G
- Xu H
- Cui J
- Chang A
- Huang H
- Hu Y
- Publication year
- Publication venue
- Cytotherapy
External Links
Snippet
Background aims With the increasing application of chimeric antigen receptor (CAR)-T cell therapy in various malignancies, an extra toxicity profile has been revealed, including a severe complication resembling hemophagocytic lymphohistiocytosis (HLH), which is …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Suresh et al. | The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis | |
| Gerfaud-Valentin et al. | Adult-onset Still's disease | |
| Wilson et al. | IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis | |
| Kumawat et al. | Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile | |
| Erpenbeck et al. | Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes | |
| TWI670074B (en) | Biological markers useful in cancer immunotherapy | |
| Meghani et al. | First-in-human intravesical delivery of pembrolizumab identifies immune activation in bladder cancer unresponsive to Bacillus Calmette-Guérin | |
| Liu et al. | Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease | |
| Zu et al. | A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)–associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapy | |
| Llosa et al. | Interleukin-17 and type 17 helper T cells in cancer management and research | |
| Negera et al. | The effects of prednisolone treatment on cytokine expression in patients with erythema nodosum leprosum reactions | |
| Hashimoto et al. | Prompt reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a relatively low basal ratio of ferritin/CRP is possibly associated with the efficacy of tocilizumab Monotherapy in severely to critically ill patients with COVID-19 | |
| Gandolfo et al. | JAK/STAT pathway targeting in primary Sjögren syndrome | |
| Wang et al. | IL‐1β Is an Androgen‐Responsive Target in Macrophages for Immunotherapy of Prostate Cancer | |
| Engel et al. | Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients | |
| Rocco et al. | Free interleukin-18 is elevated in CD22 CAR T-cell–associated hemophagocytic lymphohistiocytosis–like toxicities | |
| Yiu et al. | Efficacy and safety of emerging immunotherapies in psoriasis | |
| Korkolopoulou et al. | Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors | |
| Najafi-Fard et al. | Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy | |
| JP6671298B2 (en) | Assays for detecting TH1 and TH2 cell populations | |
| Gu et al. | Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process | |
| Chen et al. | Integrated expression profiles analysis reveals correlations between the IL-33/ST2 Axis and CD8+ T cells, regulatory T cells, and myeloid-derived suppressor cells in soft tissue sarcoma | |
| Cheng et al. | Intrinsically altered lung‐resident γδT cells control lung melanoma by producing interleukin‐17A in the elderly | |
| Cardenas et al. | IL-26 in asthma and COPD | |
| Özcan et al. | The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study |